Marino Garcia

CEO and President at Dianthus Therapeutics Inc.

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
3 years
Director since
2023

3 years of board service in total across 2 boards, counting each seat separately. Longest: Dianthus Therapeutics Inc., 3 years.

Dianthus Therapeutics Inc. Director · CEO AND PRESIDENT
3 years · Since 2023
2 months · Since 2026

Chief executive roles

Dianthus Therapeutics Inc. · CEO and President
Since September 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 7, 2026 Dianthus Therapeutics Inc. Option exercise +40,000 $8.44 $337,600
Aug 7, 2026 Dianthus Therapeutics Inc. Option exercise +126,000 $8.44 $1,063,440
Aug 7, 2026 Dianthus Therapeutics Inc. Open-market sale −10,384 $107.49 $1,116,176
Aug 7, 2026 Dianthus Therapeutics Inc. Open-market sale −23,907 $108.05 $2,583,151
Aug 7, 2026 Dianthus Therapeutics Inc. Open-market sale −2,373 $109.10 $258,894
Aug 7, 2026 Dianthus Therapeutics Inc. Open-market sale −2,536 $110.02 $279,011
Aug 7, 2026 Dianthus Therapeutics Inc. Open-market sale −800 $110.76 $88,608
Aug 7, 2026 Dianthus Therapeutics Inc. Open-market sale −104,091 $107.96 $11,237,664
Aug 7, 2026 Dianthus Therapeutics Inc. Open-market sale −21,909 $108.72 $2,381,946
Mar 16, 2026 Dianthus Therapeutics Inc. Option exercise +59,700 $6.70 $399,990
Mar 16, 2026 Dianthus Therapeutics Inc. Option exercise +5,592 $17.88 $99,985
Mar 12, 2026 Dianthus Therapeutics Inc. Option exercise +122,918 $6.70 $823,551
Mar 12, 2026 Dianthus Therapeutics Inc. Open-market sale −43,505 $80.69 $3,510,418
Mar 12, 2026 Dianthus Therapeutics Inc. Open-market sale −65,517 $81.74 $5,355,360
Mar 12, 2026 Dianthus Therapeutics Inc. Open-market sale −12,796 $82.60 $1,056,950

Questions about Marino Garcia

What boards is Marino Garcia on?

Marino Garcia sits on the boards of AgomAb Therapeutics NV and Dianthus Therapeutics Inc.

What company is Marino Garcia the CEO of?

Marino Garcia has been CEO and President of Dianthus Therapeutics Inc. since September 2023.

How long has Marino Garcia served on boards?

Our records show at least 3 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.